9.00
0.00
(0.00%)
At close: January 9 at 8:00:22 AM GMT
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
5,734.00
16,569.00
34,140.00
2,635.00
Total Liabilities Net Minority Interest
3,649.00
4,925.00
4,483.00
36,463.00
Total Equity Gross Minority Interest
2,085.00
11,644.00
29,657.00
-33,828.00
Total Capitalization
2,085.00
11,644.00
29,657.00
-33,814.00
Common Stock Equity
2,085.00
11,644.00
29,657.00
-33,814.00
Capital Lease Obligations
541.00
896.00
242.00
310.00
Net Tangible Assets
2,085.00
11,644.00
29,657.00
-33,985.00
Working Capital
1,260.00
11,222.00
29,582.00
-34,038.00
Invested Capital
2,085.00
11,644.00
30,154.00
-2,666.00
Tangible Book Value
2,085.00
11,644.00
29,657.00
-33,985.00
Total Debt
541.00
896.00
739.00
31,458.00
Net Debt
--
--
--
30,522.00
Share Issued
226,753.79
194,592.86
194,584.52
194,584.52
Ordinary Shares Number
226,753.79
194,592.86
194,584.52
194,584.52
12/31/2020 - 12/6/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SLNCF Silence Therapeutics plc
1.6350
0.00%
ROQ.L Roquefort Therapeutics plc
3.6500
-9.88%
OBD.L Oxford BioDynamics Plc
0.9110
-8.90%
GSTC GlobeStar Therapeutics Corporation
0.0004
+16.67%
OCC.AX Orthocell Limited
1.3800
-2.82%
SLN Silence Therapeutics plc
5.99
-5.52%
ITRM Iterum Therapeutics plc
1.6500
-8.33%
NNVC NanoViricides, Inc.
1.3500
-2.88%
CKPT Checkpoint Therapeutics, Inc.
3.1600
-1.56%
MESO Mesoblast Limited
17.18
0.00%